How do you monitor patients with MAC lung disease over the long term, and how do you make modifications to address poor drug tolerability? And how do you monitor the success, or lack thereof, of the antimicrobial treatment regimen?

How do you monitor patients with MAC lung disease over the long term, and how do you make modifications to address poor drug tolerability? And how do you monitor the success, or lack thereof, of the antimicrobial treatment regimen?

CLICK HERE FOR CME CREDIT

How do you monitor patients with MAC lung disease over the long term, and how do you make modifications to address poor drug tolerability? And how do you monitor the success, or lack thereof, of the antimicrobial treatment regimen? 

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics
Medical University of South Carolina
Powers-Huggins Endowed Chair for Cystic Fibrosis
University of South Carolina
Charleston, South Carolina